PRP for Knee Osteoarthritis: What Adults Over 50 Should Know

If you are over 50 and dealing with knee pain that has been getting progressively worse over the last few years, you have probably been through the standard sequence: over-the-counter anti-inflammatories, physical therapy, maybe a cortisone injection or two, and eventually the suggestion that you should start thinking about a knee replacement. Platelet-rich plasma therapy sits in a space that most patients have never been told about, between cortisone injections that wear off and surgery that you may not need yet. Here is what the evidence actually shows, who benefits, and what realistic expectations look like.

What Knee Osteoarthritis Actually Is

Osteoarthritis of the knee is not simply "wear and tear," though that phrase gets used constantly. It is a progressive loss of articular cartilage, the smooth, resilient tissue that covers the ends of the femur and tibia where they meet inside the joint. As that cartilage thins and becomes irregular, the joint loses its shock absorption, the underlying bone remodels in response to abnormal loading, and the synovial membrane becomes chronically inflamed. The result is pain, stiffness, swelling, and a gradual loss of function that makes stairs, squatting, gardening, and walking longer distances increasingly difficult.

What matters clinically is that osteoarthritis is not a uniform disease. A knee with early cartilage thinning and mild joint space narrowing is a fundamentally different biological problem than a knee with bone-on-bone contact and large osteophytes. The Kellgren-Lawrence grading system, which radiologists use to classify knee OA severity on X-ray, captures this distinction in four grades. That grading determines who is a candidate for PRP and who is not.

Why Cortisone Is a Short-Term Fix

Corticosteroid injections are the most commonly offered intervention for knee OA in conventional orthopedic practice. They work by suppressing local inflammation, and they can provide real relief for weeks to a few months. The problem is twofold. First, the relief is temporary because cortisone does not address the underlying cartilage degeneration or the biomechanical factors driving the joint's deterioration. Second, and more concerning, repeated corticosteroid exposure has been shown to accelerate cartilage loss. A 2017 randomized trial in JAMA demonstrated that patients receiving triamcinolone injections every three months for two years had significantly greater cartilage volume loss compared to saline placebo. You feel better for six weeks while the joint silently gets worse.

This does not mean cortisone has no role. For an acute flare with significant effusion, a single corticosteroid injection to calm the joint down before starting a regenerative or rehabilitative program can be entirely appropriate. But serial cortisone injections as the primary management strategy for progressive knee OA is a losing proposition, and patients over 50 deserve to know that.

How PRP Works for Knee Osteoarthritis

Platelet-rich plasma is autologous, meaning it is prepared from your own blood. A blood draw is performed in the office, the sample is centrifuged to concentrate the platelet fraction, and the resulting concentrate is injected into the knee joint. The entire preparation and injection process happens in a single visit. There is no donor tissue, no synthetic material, and no stem cells involved. PRP is FDA-compliant as a point-of-care blood product preparation.

The concentrated platelets release a cascade of growth factors when activated, including platelet-derived growth factor (PDGF), transforming growth factor beta (TGF-beta), vascular endothelial growth factor (VEGF), and insulin-like growth factor (IGF-1). These signaling molecules do several things that matter for an osteoarthritic knee:

• Modulate the inflammatory environment by shifting the joint from chronic, destructive inflammation toward a controlled healing response
• Stimulate chondrocyte activity to promote cartilage matrix production in areas where the cartilage is thinning but not yet destroyed
• Improve synovial fluid quality by stimulating hyaluronic acid production from synoviocytes, which improves joint lubrication
• Recruit progenitor cells to the joint surface to participate in tissue maintenance and repair

The key distinction between PRP and cortisone is directionality. Cortisone suppresses the biology of the joint. PRP attempts to redirect it toward repair. That is why PRP has a slower onset but a longer duration of benefit in most patients who respond.

Who Is a Candidate: Kellgren-Lawrence Grading

Not every arthritic knee responds to PRP, and patient selection is the single most important factor in outcomes. The Kellgren-Lawrence (KL) grading system provides the clearest framework for determining candidacy:

• Grade I (Doubtful): Minimal osteophyte formation, no joint space narrowing. These patients often respond very well to PRP, sometimes with near-complete symptom resolution. The cartilage is early in its degeneration, and there is substantial biological substrate for the growth factors to work with.
• Grade II (Mild): Definite osteophytes, possible mild joint space narrowing. This is the sweet spot for PRP. The disease is established enough to cause real symptoms but early enough that the cartilage and synovium can still mount a meaningful regenerative response.
• Grade III (Moderate): Multiple osteophytes, definite joint space narrowing, some sclerosis. PRP can still help many Grade III patients, particularly those whose pain exceeds what the imaging would predict, suggesting a significant inflammatory component alongside the structural degeneration. Expectations should be calibrated: the goal is meaningful pain reduction and functional improvement, not reversal of the arthritis.
• Grade IV (Severe): Large osteophytes, marked joint space narrowing, severe sclerosis, definite bony deformity. These knees have lost most of their cartilage. There is simply not enough biological substrate remaining for PRP to produce a clinically meaningful response. Grade IV knees are surgical candidates, and offering PRP to a Grade IV patient in place of an appropriate surgical referral is poor medicine.

In well-selected patients with KL grades I through III, the clinical literature and my own practice experience consistently show a 60 to 70 percent rate of meaningful improvement, defined as a substantial reduction in pain and a measurable improvement in function that persists beyond six months.

What to Expect: Timeline and Realistic Outcomes

PRP is not a quick fix, and patients who expect immediate relief will be disappointed. The timeline follows the biology of tissue repair, not the pharmacology of an anti-inflammatory.

In the first one to two weeks after injection, some patients experience a temporary increase in knee soreness and mild swelling. This is expected. The concentrated platelets are initiating an inflammatory signaling cascade, which is the mechanism of action, not a side effect. During this window, you should avoid anti-inflammatory medications (NSAIDs), which would blunt the very response you are paying for.

Between four and eight weeks, most responders begin to notice improvement. The knee feels less stiff in the morning. Stairs become less painful. Walking distance improves. This is when the growth factor signaling is translating into actual tissue-level change.

Peak improvement typically occurs at three to six months. By this point, the regenerative response has had time to improve cartilage matrix quality, modulate the chronic inflammatory environment, and restore some degree of synovial homeostasis. In responders, this improvement can persist for 12 to 18 months, and in some patients longer.

Some patients benefit from a series of two to three injections spaced four to six weeks apart, rather than a single injection. The decision to do a series versus a single injection depends on the severity of the arthritis, the patient's response to the first injection, and the clinical assessment at follow-up.

Why Biomechanics Matter: How OMT Complements PRP

Here is the piece that most practices offering PRP miss entirely. A knee does not degenerate in isolation. It degenerates in the context of how the entire lower extremity loads it. If you have a pelvic obliquity that shifts your weight asymmetrically onto one knee, that knee is absorbing more force with every step. If your hip lacks internal rotation, the knee compensates by accepting rotational stress it was not designed to handle. If your ankle is stiff from an old sprain, the kinetic chain above it adapts, and the knee is usually where the adaptation becomes symptomatic.

Injecting PRP into a knee that continues to be mechanically overloaded by upstream dysfunction is like repairing a pothole on a road that keeps getting driven over by overweight trucks. The repair will not hold because the force that caused the damage is still present.

Osteopathic manipulative treatment addresses these biomechanical contributors directly. Through hands-on evaluation and treatment of the pelvis, hips, lumbar spine, and lower extremities, OMT identifies and corrects the structural dysfunctions that are driving abnormal knee loading. When OMT is performed before and after PRP injection, the regenerative response occurs in a joint that is being loaded correctly rather than being perpetually re-stressed by the same mechanical faults that accelerated its degeneration.

This combination, correcting the mechanical environment with OMT and stimulating tissue repair with PRP, is the approach that produces the most durable results in my practice. Neither intervention alone addresses both dimensions of the problem.

What PRP Is Not

Transparency matters. PRP is not stem cell therapy. It does not contain stem cells, and any practice marketing PRP as a stem cell treatment is being misleading. PRP is not a cure for osteoarthritis. It does not regrow cartilage to its original state. It modulates the joint environment, slows progression, and improves symptoms in the majority of well-selected patients. It is also not an alternative to surgery for patients who genuinely need a joint replacement. If your knee is bone-on-bone with significant deformity and mechanical symptoms, PRP is not the answer, and a physician who tells you otherwise is not serving your interest.

What PRP is, for the right patient at the right stage, is a biologically rational intervention that works with your body's own healing mechanisms rather than against them. For adults over 50 with KL grade I through III knee osteoarthritis who want to maintain an active life without rushing toward surgery, it is one of the most useful tools available.